nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—UGT1A1—Mycophenolic acid—psoriasis	0.504	0.642	CbGbCtD
Dolutegravir—UGT1A1—Mycophenolate mofetil—psoriasis	0.282	0.358	CbGbCtD
Dolutegravir—Inflammation—Methotrexate—psoriasis	0.000636	0.00301	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Hydrocortisone—psoriasis	0.000635	0.00301	CcSEcCtD
Dolutegravir—Hyperglycaemia—Cyclosporine—psoriasis	0.000631	0.00299	CcSEcCtD
Dolutegravir—Dizziness—Methoxsalen—psoriasis	0.000624	0.00296	CcSEcCtD
Dolutegravir—Hypersensitivity—Calcitriol—psoriasis	0.00062	0.00294	CcSEcCtD
Dolutegravir—Hyperglycaemia—Mycophenolate mofetil—psoriasis	0.000616	0.00292	CcSEcCtD
Dolutegravir—Renal failure—Cyclosporine—psoriasis	0.000614	0.00291	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Acitretin—psoriasis	0.000612	0.0029	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000609	0.00289	CcSEcCtD
Dolutegravir—Mental disorder—Mycophenolic acid—psoriasis	0.000607	0.00288	CcSEcCtD
Dolutegravir—Asthenia—Calcitriol—psoriasis	0.000604	0.00286	CcSEcCtD
Dolutegravir—Renal failure—Mycophenolate mofetil—psoriasis	0.000599	0.00284	CcSEcCtD
Dolutegravir—Pruritus—Calcitriol—psoriasis	0.000595	0.00282	CcSEcCtD
Dolutegravir—Rash—Methoxsalen—psoriasis	0.000595	0.00282	CcSEcCtD
Dolutegravir—Dermatitis—Methoxsalen—psoriasis	0.000595	0.00282	CcSEcCtD
Dolutegravir—Flatulence—Mycophenolic acid—psoriasis	0.000594	0.00282	CcSEcCtD
Dolutegravir—Abdominal pain—Acitretin—psoriasis	0.000592	0.0028	CcSEcCtD
Dolutegravir—Headache—Methoxsalen—psoriasis	0.000591	0.0028	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Cyclosporine—psoriasis	0.00059	0.0028	CcSEcCtD
Dolutegravir—Nervous system disorder—Hydroxyurea—psoriasis	0.000576	0.00273	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Mycophenolate mofetil—psoriasis	0.000576	0.00273	CcSEcCtD
Dolutegravir—Diarrhoea—Calcitriol—psoriasis	0.000576	0.00273	CcSEcCtD
Dolutegravir—Skin disorder—Hydroxyurea—psoriasis	0.000571	0.00271	CcSEcCtD
Dolutegravir—Nausea—Methoxsalen—psoriasis	0.000561	0.00266	CcSEcCtD
Dolutegravir—Hepatitis—Cyclosporine—psoriasis	0.00056	0.00266	CcSEcCtD
Dolutegravir—Urinary tract disorder—Cyclosporine—psoriasis	0.000553	0.00262	CcSEcCtD
Dolutegravir—Hypersensitivity—Acitretin—psoriasis	0.000551	0.00261	CcSEcCtD
Dolutegravir—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.00055	0.00261	CcSEcCtD
Dolutegravir—Urethral disorder—Cyclosporine—psoriasis	0.000549	0.0026	CcSEcCtD
Dolutegravir—Hepatitis—Mycophenolate mofetil—psoriasis	0.000547	0.00259	CcSEcCtD
Dolutegravir—Vertigo—Mycophenolic acid—psoriasis	0.000542	0.00257	CcSEcCtD
Dolutegravir—Urinary tract disorder—Mycophenolate mofetil—psoriasis	0.00054	0.00256	CcSEcCtD
Dolutegravir—Asthenia—Acitretin—psoriasis	0.000537	0.00255	CcSEcCtD
Dolutegravir—Urethral disorder—Mycophenolate mofetil—psoriasis	0.000536	0.00254	CcSEcCtD
Dolutegravir—Vomiting—Calcitriol—psoriasis	0.000535	0.00254	CcSEcCtD
Dolutegravir—Rash—Calcitriol—psoriasis	0.00053	0.00251	CcSEcCtD
Dolutegravir—Dermatitis—Calcitriol—psoriasis	0.00053	0.00251	CcSEcCtD
Dolutegravir—Pruritus—Acitretin—psoriasis	0.000529	0.00251	CcSEcCtD
Dolutegravir—Pruritus—Fluocinolone Acetonide—psoriasis	0.000528	0.0025	CcSEcCtD
Dolutegravir—Headache—Calcitriol—psoriasis	0.000527	0.0025	CcSEcCtD
Dolutegravir—Diarrhoea—Acitretin—psoriasis	0.000512	0.00243	CcSEcCtD
Dolutegravir—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000511	0.00242	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.00051	0.00242	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000507	0.0024	CcSEcCtD
Dolutegravir—Fatigue—Hydroxyurea—psoriasis	0.000507	0.0024	CcSEcCtD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—VDR—psoriasis	0.000502	0.168	CbGpPWpGaD
Dolutegravir—Nausea—Calcitriol—psoriasis	0.0005	0.00237	CcSEcCtD
Dolutegravir—Dizziness—Acitretin—psoriasis	0.000495	0.00235	CcSEcCtD
Dolutegravir—Dizziness—Fluocinolone Acetonide—psoriasis	0.000493	0.00234	CcSEcCtD
Dolutegravir—Mental disorder—Cyclosporine—psoriasis	0.000491	0.00233	CcSEcCtD
Dolutegravir—Nervous system disorder—Mycophenolic acid—psoriasis	0.000483	0.00229	CcSEcCtD
Dolutegravir—Flatulence—Cyclosporine—psoriasis	0.000481	0.00228	CcSEcCtD
Dolutegravir—Hyperglycaemia—Dexamethasone—psoriasis	0.000479	0.00227	CcSEcCtD
Dolutegravir—Hyperglycaemia—Betamethasone—psoriasis	0.000479	0.00227	CcSEcCtD
Dolutegravir—Mental disorder—Mycophenolate mofetil—psoriasis	0.000479	0.00227	CcSEcCtD
Dolutegravir—Skin disorder—Mycophenolic acid—psoriasis	0.000478	0.00227	CcSEcCtD
Dolutegravir—Vomiting—Acitretin—psoriasis	0.000476	0.00226	CcSEcCtD
Dolutegravir—Vomiting—Fluocinolone Acetonide—psoriasis	0.000474	0.00225	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Prednisone—psoriasis	0.000472	0.00224	CcSEcCtD
Dolutegravir—Rash—Acitretin—psoriasis	0.000472	0.00224	CcSEcCtD
Dolutegravir—Dermatitis—Acitretin—psoriasis	0.000471	0.00223	CcSEcCtD
Dolutegravir—Rash—Fluocinolone Acetonide—psoriasis	0.000471	0.00223	CcSEcCtD
Dolutegravir—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00047	0.00223	CcSEcCtD
Dolutegravir—Flatulence—Mycophenolate mofetil—psoriasis	0.000469	0.00222	CcSEcCtD
Dolutegravir—Headache—Acitretin—psoriasis	0.000469	0.00222	CcSEcCtD
Dolutegravir—Headache—Fluocinolone Acetonide—psoriasis	0.000467	0.00222	CcSEcCtD
Dolutegravir—Immune system disorder—Hydrocortisone—psoriasis	0.00045	0.00213	CcSEcCtD
Dolutegravir—Insomnia—Mycophenolic acid—psoriasis	0.000445	0.00211	CcSEcCtD
Dolutegravir—Nausea—Acitretin—psoriasis	0.000444	0.00211	CcSEcCtD
Dolutegravir—Nausea—Fluocinolone Acetonide—psoriasis	0.000443	0.0021	CcSEcCtD
Dolutegravir—Vertigo—Cyclosporine—psoriasis	0.000438	0.00208	CcSEcCtD
Dolutegravir—Mental disorder—Hydrocortisone—psoriasis	0.000436	0.00207	CcSEcCtD
Dolutegravir—Hypersensitivity—Hydroxyurea—psoriasis	0.000433	0.00205	CcSEcCtD
Dolutegravir—Neutropenia—Prednisone—psoriasis	0.000433	0.00205	CcSEcCtD
Dolutegravir—Vertigo—Mycophenolate mofetil—psoriasis	0.000427	0.00203	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000425	0.00201	CcSEcCtD
Dolutegravir—Fatigue—Mycophenolic acid—psoriasis	0.000424	0.00201	CcSEcCtD
Dolutegravir—Asthenia—Hydroxyurea—psoriasis	0.000422	0.002	CcSEcCtD
Dolutegravir—Hyperglycaemia—Prednisone—psoriasis	0.000418	0.00198	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000412	0.00195	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000402	0.00191	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000402	0.00191	CcSEcCtD
Dolutegravir—Diarrhoea—Hydroxyurea—psoriasis	0.000402	0.00191	CcSEcCtD
Dolutegravir—Vertigo—Prednisolone—psoriasis	0.000399	0.00189	CcSEcCtD
Dolutegravir—Nervous system disorder—Cyclosporine—psoriasis	0.00039	0.00185	CcSEcCtD
Dolutegravir—Vertigo—Hydrocortisone—psoriasis	0.000389	0.00185	CcSEcCtD
Dolutegravir—Abdominal pain—Mycophenolic acid—psoriasis	0.000389	0.00184	CcSEcCtD
Dolutegravir—Dizziness—Hydroxyurea—psoriasis	0.000389	0.00184	CcSEcCtD
Dolutegravir—Skin disorder—Cyclosporine—psoriasis	0.000387	0.00183	CcSEcCtD
Dolutegravir—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000381	0.00181	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000379	0.126	CbGpPWpGaD
Dolutegravir—Skin disorder—Mycophenolate mofetil—psoriasis	0.000377	0.00179	CcSEcCtD
Dolutegravir—Vomiting—Hydroxyurea—psoriasis	0.000374	0.00177	CcSEcCtD
Dolutegravir—Abdominal discomfort—Methotrexate—psoriasis	0.000371	0.00176	CcSEcCtD
Dolutegravir—Rash—Hydroxyurea—psoriasis	0.00037	0.00176	CcSEcCtD
Dolutegravir—Dermatitis—Hydroxyurea—psoriasis	0.00037	0.00175	CcSEcCtD
Dolutegravir—Headache—Hydroxyurea—psoriasis	0.000368	0.00174	CcSEcCtD
Dolutegravir—Vertigo—Triamcinolone—psoriasis	0.000367	0.00174	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000367	0.00174	CcSEcCtD
Dolutegravir—Neutropenia—Methotrexate—psoriasis	0.000362	0.00171	CcSEcCtD
Dolutegravir—Insomnia—Cyclosporine—psoriasis	0.00036	0.00171	CcSEcCtD
Dolutegravir—Asthenia—Mycophenolic acid—psoriasis	0.000353	0.00167	CcSEcCtD
Dolutegravir—Insomnia—Mycophenolate mofetil—psoriasis	0.000351	0.00166	CcSEcCtD
Dolutegravir—Nausea—Hydroxyurea—psoriasis	0.000349	0.00165	CcSEcCtD
Dolutegravir—Pruritus—Mycophenolic acid—psoriasis	0.000348	0.00165	CcSEcCtD
Dolutegravir—Nervous system disorder—Hydrocortisone—psoriasis	0.000347	0.00164	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000344	0.00163	CcSEcCtD
Dolutegravir—Skin disorder—Hydrocortisone—psoriasis	0.000344	0.00163	CcSEcCtD
Dolutegravir—Fatigue—Cyclosporine—psoriasis	0.000343	0.00163	CcSEcCtD
Dolutegravir—Renal failure—Methotrexate—psoriasis	0.000339	0.00161	CcSEcCtD
Dolutegravir—Diarrhoea—Mycophenolic acid—psoriasis	0.000337	0.0016	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000335	0.00159	CcSEcCtD
Dolutegravir—Immune system disorder—Prednisone—psoriasis	0.000335	0.00159	CcSEcCtD
Dolutegravir—Vertigo—Dexamethasone—psoriasis	0.000333	0.00158	CcSEcCtD
Dolutegravir—Vertigo—Betamethasone—psoriasis	0.000333	0.00158	CcSEcCtD
Dolutegravir—Insomnia—Prednisolone—psoriasis	0.000328	0.00155	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Methotrexate—psoriasis	0.000326	0.00155	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Cyclosporine—psoriasis	0.000326	0.00154	CcSEcCtD
Dolutegravir—Dizziness—Mycophenolic acid—psoriasis	0.000325	0.00154	CcSEcCtD
Dolutegravir—Mental disorder—Prednisone—psoriasis	0.000325	0.00154	CcSEcCtD
Dolutegravir—Insomnia—Hydrocortisone—psoriasis	0.00032	0.00152	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000318	0.00151	CcSEcCtD
Dolutegravir—Abdominal pain—Cyclosporine—psoriasis	0.000315	0.00149	CcSEcCtD
Dolutegravir—Vomiting—Mycophenolic acid—psoriasis	0.000313	0.00148	CcSEcCtD
Dolutegravir—Rash—Mycophenolic acid—psoriasis	0.00031	0.00147	CcSEcCtD
Dolutegravir—Dermatitis—Mycophenolic acid—psoriasis	0.00031	0.00147	CcSEcCtD
Dolutegravir—Hepatitis—Methotrexate—psoriasis	0.00031	0.00147	CcSEcCtD
Dolutegravir—Headache—Mycophenolic acid—psoriasis	0.000308	0.00146	CcSEcCtD
Dolutegravir—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000307	0.00146	CcSEcCtD
Dolutegravir—Urinary tract disorder—Methotrexate—psoriasis	0.000306	0.00145	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000305	0.00145	CcSEcCtD
Dolutegravir—Fatigue—Hydrocortisone—psoriasis	0.000305	0.00145	CcSEcCtD
Dolutegravir—Urethral disorder—Methotrexate—psoriasis	0.000304	0.00144	CcSEcCtD
Dolutegravir—Insomnia—Triamcinolone—psoriasis	0.000301	0.00143	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL13—psoriasis	0.000299	0.0998	CbGpPWpGaD
Dolutegravir—Nervous system disorder—Dexamethasone—psoriasis	0.000296	0.00141	CcSEcCtD
Dolutegravir—Nervous system disorder—Betamethasone—psoriasis	0.000296	0.00141	CcSEcCtD
Dolutegravir—Hypersensitivity—Cyclosporine—psoriasis	0.000293	0.00139	CcSEcCtD
Dolutegravir—Nausea—Mycophenolic acid—psoriasis	0.000292	0.00139	CcSEcCtD
Dolutegravir—Vertigo—Prednisone—psoriasis	0.00029	0.00137	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000289	0.00137	CcSEcCtD
Dolutegravir—Fatigue—Triamcinolone—psoriasis	0.000287	0.00136	CcSEcCtD
Dolutegravir—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000286	0.00136	CcSEcCtD
Dolutegravir—Asthenia—Cyclosporine—psoriasis	0.000286	0.00135	CcSEcCtD
Dolutegravir—POU2F2—BCR signaling pathway—NFKBIA—psoriasis	0.000282	0.0941	CbGpPWpGaD
Dolutegravir—Pruritus—Cyclosporine—psoriasis	0.000282	0.00134	CcSEcCtD
Dolutegravir—Immune system disorder—Methotrexate—psoriasis	0.00028	0.00133	CcSEcCtD
Dolutegravir—Abdominal pain—Hydrocortisone—psoriasis	0.00028	0.00133	CcSEcCtD
Dolutegravir—Asthenia—Mycophenolate mofetil—psoriasis	0.000279	0.00132	CcSEcCtD
Dolutegravir—Pruritus—Mycophenolate mofetil—psoriasis	0.000275	0.0013	CcSEcCtD
Dolutegravir—Insomnia—Betamethasone—psoriasis	0.000273	0.0013	CcSEcCtD
Dolutegravir—Insomnia—Dexamethasone—psoriasis	0.000273	0.0013	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000273	0.00129	CcSEcCtD
Dolutegravir—Diarrhoea—Cyclosporine—psoriasis	0.000272	0.00129	CcSEcCtD
Dolutegravir—Mental disorder—Methotrexate—psoriasis	0.000271	0.00129	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisolone—psoriasis	0.000267	0.00127	CcSEcCtD
Dolutegravir—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000266	0.00126	CcSEcCtD
Dolutegravir—Dizziness—Cyclosporine—psoriasis	0.000263	0.00125	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000261	0.00124	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Betamethasone—psoriasis	0.000261	0.00124	CcSEcCtD
Dolutegravir—Hypersensitivity—Hydrocortisone—psoriasis	0.000261	0.00124	CcSEcCtD
Dolutegravir—Fatigue—Dexamethasone—psoriasis	0.000261	0.00124	CcSEcCtD
Dolutegravir—Fatigue—Betamethasone—psoriasis	0.000261	0.00124	CcSEcCtD
Dolutegravir—Nervous system disorder—Prednisone—psoriasis	0.000258	0.00122	CcSEcCtD
Dolutegravir—Dizziness—Mycophenolate mofetil—psoriasis	0.000257	0.00122	CcSEcCtD
Dolutegravir—Skin disorder—Prednisone—psoriasis	0.000256	0.00121	CcSEcCtD
Dolutegravir—Asthenia—Hydrocortisone—psoriasis	0.000254	0.0012	CcSEcCtD
Dolutegravir—Vomiting—Cyclosporine—psoriasis	0.000253	0.0012	CcSEcCtD
Dolutegravir—Rash—Cyclosporine—psoriasis	0.000251	0.00119	CcSEcCtD
Dolutegravir—Dermatitis—Cyclosporine—psoriasis	0.000251	0.00119	CcSEcCtD
Dolutegravir—Pruritus—Hydrocortisone—psoriasis	0.00025	0.00119	CcSEcCtD
Dolutegravir—Headache—Cyclosporine—psoriasis	0.000249	0.00118	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Dexamethasone—psoriasis	0.000247	0.00117	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Betamethasone—psoriasis	0.000247	0.00117	CcSEcCtD
Dolutegravir—Vomiting—Mycophenolate mofetil—psoriasis	0.000247	0.00117	CcSEcCtD
Dolutegravir—Hypersensitivity—Triamcinolone—psoriasis	0.000245	0.00116	CcSEcCtD
Dolutegravir—Rash—Mycophenolate mofetil—psoriasis	0.000245	0.00116	CcSEcCtD
Dolutegravir—Dermatitis—Mycophenolate mofetil—psoriasis	0.000245	0.00116	CcSEcCtD
Dolutegravir—Headache—Mycophenolate mofetil—psoriasis	0.000243	0.00115	CcSEcCtD
Dolutegravir—Vertigo—Methotrexate—psoriasis	0.000242	0.00115	CcSEcCtD
Dolutegravir—Diarrhoea—Hydrocortisone—psoriasis	0.000242	0.00115	CcSEcCtD
Dolutegravir—Dizziness—Prednisolone—psoriasis	0.00024	0.00114	CcSEcCtD
Dolutegravir—Asthenia—Triamcinolone—psoriasis	0.000239	0.00113	CcSEcCtD
Dolutegravir—Abdominal pain—Dexamethasone—psoriasis	0.000239	0.00113	CcSEcCtD
Dolutegravir—Abdominal pain—Betamethasone—psoriasis	0.000239	0.00113	CcSEcCtD
Dolutegravir—Insomnia—Prednisone—psoriasis	0.000238	0.00113	CcSEcCtD
Dolutegravir—Nausea—Cyclosporine—psoriasis	0.000236	0.00112	CcSEcCtD
Dolutegravir—Pruritus—Triamcinolone—psoriasis	0.000236	0.00112	CcSEcCtD
Dolutegravir—Dizziness—Hydrocortisone—psoriasis	0.000234	0.00111	CcSEcCtD
Dolutegravir—Nausea—Mycophenolate mofetil—psoriasis	0.000231	0.00109	CcSEcCtD
Dolutegravir—Rash—Prednisolone—psoriasis	0.000228	0.00108	CcSEcCtD
Dolutegravir—Dermatitis—Prednisolone—psoriasis	0.000228	0.00108	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000228	0.00108	CcSEcCtD
Dolutegravir—Fatigue—Prednisone—psoriasis	0.000227	0.00108	CcSEcCtD
Dolutegravir—Headache—Prednisolone—psoriasis	0.000227	0.00108	CcSEcCtD
Dolutegravir—Vomiting—Hydrocortisone—psoriasis	0.000225	0.00107	CcSEcCtD
Dolutegravir—Rash—Hydrocortisone—psoriasis	0.000223	0.00106	CcSEcCtD
Dolutegravir—Dermatitis—Hydrocortisone—psoriasis	0.000223	0.00106	CcSEcCtD
Dolutegravir—Headache—Hydrocortisone—psoriasis	0.000222	0.00105	CcSEcCtD
Dolutegravir—Dizziness—Triamcinolone—psoriasis	0.00022	0.00104	CcSEcCtD
Dolutegravir—Asthenia—Dexamethasone—psoriasis	0.000217	0.00103	CcSEcCtD
Dolutegravir—Asthenia—Betamethasone—psoriasis	0.000217	0.00103	CcSEcCtD
Dolutegravir—Nervous system disorder—Methotrexate—psoriasis	0.000216	0.00102	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Prednisone—psoriasis	0.000215	0.00102	CcSEcCtD
Dolutegravir—Nausea—Prednisolone—psoriasis	0.000215	0.00102	CcSEcCtD
Dolutegravir—Pruritus—Betamethasone—psoriasis	0.000214	0.00101	CcSEcCtD
Dolutegravir—Pruritus—Dexamethasone—psoriasis	0.000214	0.00101	CcSEcCtD
Dolutegravir—Skin disorder—Methotrexate—psoriasis	0.000214	0.00101	CcSEcCtD
Dolutegravir—Vomiting—Triamcinolone—psoriasis	0.000212	0.001	CcSEcCtD
Dolutegravir—Nausea—Hydrocortisone—psoriasis	0.00021	0.000996	CcSEcCtD
Dolutegravir—Rash—Triamcinolone—psoriasis	0.00021	0.000996	CcSEcCtD
Dolutegravir—Dermatitis—Triamcinolone—psoriasis	0.00021	0.000995	CcSEcCtD
Dolutegravir—Headache—Triamcinolone—psoriasis	0.000209	0.000989	CcSEcCtD
Dolutegravir—Abdominal pain—Prednisone—psoriasis	0.000208	0.000986	CcSEcCtD
Dolutegravir—Diarrhoea—Betamethasone—psoriasis	0.000207	0.00098	CcSEcCtD
Dolutegravir—Diarrhoea—Dexamethasone—psoriasis	0.000207	0.00098	CcSEcCtD
Dolutegravir—Dizziness—Dexamethasone—psoriasis	0.0002	0.000947	CcSEcCtD
Dolutegravir—Dizziness—Betamethasone—psoriasis	0.0002	0.000947	CcSEcCtD
Dolutegravir—Insomnia—Methotrexate—psoriasis	0.000199	0.000943	CcSEcCtD
Dolutegravir—Nausea—Triamcinolone—psoriasis	0.000198	0.000938	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisone—psoriasis	0.000194	0.000919	CcSEcCtD
Dolutegravir—Vomiting—Betamethasone—psoriasis	0.000192	0.000911	CcSEcCtD
Dolutegravir—Vomiting—Dexamethasone—psoriasis	0.000192	0.000911	CcSEcCtD
Dolutegravir—Rash—Betamethasone—psoriasis	0.000191	0.000903	CcSEcCtD
Dolutegravir—Rash—Dexamethasone—psoriasis	0.000191	0.000903	CcSEcCtD
Dolutegravir—Dermatitis—Dexamethasone—psoriasis	0.00019	0.000903	CcSEcCtD
Dolutegravir—Dermatitis—Betamethasone—psoriasis	0.00019	0.000903	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Methotrexate—psoriasis	0.00019	0.0009	CcSEcCtD
Dolutegravir—Fatigue—Methotrexate—psoriasis	0.00019	0.000899	CcSEcCtD
Dolutegravir—Headache—Betamethasone—psoriasis	0.000189	0.000898	CcSEcCtD
Dolutegravir—Headache—Dexamethasone—psoriasis	0.000189	0.000898	CcSEcCtD
Dolutegravir—Asthenia—Prednisone—psoriasis	0.000189	0.000895	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL10—psoriasis	0.000187	0.0624	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—JUN—psoriasis	0.000187	0.0624	CbGpPWpGaD
Dolutegravir—Pruritus—Prednisone—psoriasis	0.000186	0.000883	CcSEcCtD
Dolutegravir—Diarrhoea—Prednisone—psoriasis	0.00018	0.000854	CcSEcCtD
Dolutegravir—POU2F2—BCR signaling pathway—NFKB1—psoriasis	0.00018	0.0601	CbGpPWpGaD
Dolutegravir—Gastrointestinal pain—Methotrexate—psoriasis	0.00018	0.000853	CcSEcCtD
Dolutegravir—Nausea—Dexamethasone—psoriasis	0.00018	0.000851	CcSEcCtD
Dolutegravir—Nausea—Betamethasone—psoriasis	0.00018	0.000851	CcSEcCtD
Dolutegravir—Dizziness—Prednisone—psoriasis	0.000174	0.000825	CcSEcCtD
Dolutegravir—Abdominal pain—Methotrexate—psoriasis	0.000174	0.000824	CcSEcCtD
Dolutegravir—Vomiting—Prednisone—psoriasis	0.000167	0.000793	CcSEcCtD
Dolutegravir—Rash—Prednisone—psoriasis	0.000166	0.000787	CcSEcCtD
Dolutegravir—Dermatitis—Prednisone—psoriasis	0.000166	0.000786	CcSEcCtD
Dolutegravir—Headache—Prednisone—psoriasis	0.000165	0.000782	CcSEcCtD
Dolutegravir—Hypersensitivity—Methotrexate—psoriasis	0.000162	0.000768	CcSEcCtD
Dolutegravir—Asthenia—Methotrexate—psoriasis	0.000158	0.000748	CcSEcCtD
Dolutegravir—Nausea—Prednisone—psoriasis	0.000156	0.000741	CcSEcCtD
Dolutegravir—Pruritus—Methotrexate—psoriasis	0.000156	0.000738	CcSEcCtD
Dolutegravir—Diarrhoea—Methotrexate—psoriasis	0.000151	0.000714	CcSEcCtD
Dolutegravir—Dizziness—Methotrexate—psoriasis	0.000145	0.00069	CcSEcCtD
Dolutegravir—Vomiting—Methotrexate—psoriasis	0.00014	0.000663	CcSEcCtD
Dolutegravir—Rash—Methotrexate—psoriasis	0.000139	0.000658	CcSEcCtD
Dolutegravir—Dermatitis—Methotrexate—psoriasis	0.000139	0.000657	CcSEcCtD
Dolutegravir—Headache—Methotrexate—psoriasis	0.000138	0.000653	CcSEcCtD
Dolutegravir—Nausea—Methotrexate—psoriasis	0.000131	0.000619	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000102	0.0341	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	9.82e-05	0.0328	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—JUN—psoriasis	9.51e-05	0.0317	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NFKB1—psoriasis	9.15e-05	0.0306	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP2S1—psoriasis	8.81e-05	0.0294	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP2S1—psoriasis	8.69e-05	0.029	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—VEGFA—psoriasis	8.31e-05	0.0277	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—psoriasis	7.12e-05	0.0238	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL6—psoriasis	5.74e-05	0.0192	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—TGFA—psoriasis	4.91e-05	0.0164	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.22e-05	0.0141	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.65e-05	0.0122	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.73e-05	0.00912	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NDUFA5—psoriasis	1.77e-05	0.00592	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP2S1—psoriasis	1.51e-05	0.00503	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CARM1—psoriasis	7.36e-06	0.00246	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CAT—psoriasis	4.53e-06	0.00151	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOE—psoriasis	3.52e-06	0.00117	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARG—psoriasis	3.06e-06	0.00102	CbGpPWpGaD
